Article (Scientific journals)
Polymorphisms in Type-II SH2 domain-containing Inositol 5-Phosphatase (INPPL1, SHIP2) are Associated with Physiological Abnormalities of the Metabolic Syndrome
Kaisaki, P. J.; Delépine, M.; Woon, P. Y. et al.
2004In Diabetes, 53, p. 1900-1904
Peer Reviewed verified by ORBi
 

Files


Full Text
KaisakiPM_diabetes_2004.pdf
Publisher postprint (89.97 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Polymorphisms; INPPL1; SHIP2; Metabolic Syndrome; Physiological Abnormalities
Abstract :
[en] Type II SH2 domain-containing inositol 5-phosphatase (INPPL1, or SHIP2) plays an important role in the control of insulin sensitivity. INPPL1 mutations affecting gene function have been found in rat models of type 2 diabetes and hypertension and in type 2 diabetic patients. We investigated the influence of nucleotide variation in INPPL1 on components of the metabolic syndrome. Following comprehensive resequencing of the gene, we genotyped 12 informative polymorphisms in 1,304 individuals from 424 British type 2 diabetes families that were characterized for several metabolic phenotypes. We have found highly significant associations of single nucleotide polymorphisms (SNPs) and haplotypes of INPPL1 with hypertension as well as with other components of the metabolic syndrome. In a cohort of 905 French type 2 diabetic patients, we found evidence of association of INPPL1 SNPs with the presence of hypertension. We conclude that INPPL1 variants may impact susceptibility to disease and/or to subphenotypes involved in the metabolic syndrome in some diabetic patients
Disciplines :
Biochemistry, biophysics & molecular biology
Genetics & genetic processes
Author, co-author :
Kaisaki, P. J.;  University of Oxford, Oxford, UK > The Wellcome Trust Centre for Human Genetics
Delépine, M.;  National Centre for Genotyping, Evry, France
Woon, P. Y.;  University of Oxford, Oxford, UK > The Wellcome Trust Centre for Human Genetics
Sebag-Montefiore, L.;  University of Oxford, Oxford, UK > The Wellcome Trust Centre for Human Genetics
Wilder, S. P.;  University of Oxford, Oxford, UK > The Wellcome Trust Centre for Human Genetics
Menzel, S.;  University of Oxford, Oxford, UK > The Wellcome Trust Centre for Human Genetics
Vionnet, N.;  National Centre for Genotyping, Evry, France
Marion, E.;  Université Libre de Bruxelles - ULB > Institut de Recherches en Biologie Humaine et Moléculaire
Riveline, J. P.;  Service d’Endocrinologie-Diabétologie, CH Sud Francilien, Corbeil-Essonnes, France
Charpentier, G.;  4Service d’Endocrinologie-Diabétologie, CH Sud Francilien, Corbeil-Essonnes, France
Schurmans, Stéphane  ;  Université de Liège - ULiège > Département de sciences fonctionnelles > Biochimie métabolique vétérinaire
Levy, J. C.;  University of Oxford > Oxford Centre for Diabetes, Endocrinology and Metabolism
Lathrop, M.;  National Centre for Genotyping, Evry, France
Farrall, M.;  University of Oxford > Department of Cardiovascular Medicine
Gauguier, D.;  University of Oxford, Oxford, UK > The Wellcome Trust Centre for Human Genetics
More authors (5 more) Less
Language :
English
Title :
Polymorphisms in Type-II SH2 domain-containing Inositol 5-Phosphatase (INPPL1, SHIP2) are Associated with Physiological Abnormalities of the Metabolic Syndrome
Publication date :
2004
Journal title :
Diabetes
ISSN :
0012-1797
eISSN :
1939-327X
Publisher :
American Diabetes Association, Alexandria, United States - Virginia
Volume :
53
Pages :
1900-1904
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
The Wellcome Trust (057733), the Wellcome Cardiovascular Functional Genomics Initiative (066780/Z/01/Z), and Diabetes U.K. (RD96/0001270)
Available on ORBi :
since 21 January 2010

Statistics


Number of views
51 (4 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
72
Scopus citations®
without self-citations
60
OpenCitations
 
73

Bibliography


Similar publications



Contact ORBi